These are short updates on AbbVie informational items, news or events where we’ll have a presence.

Shining a Light on a Rare Blood Cancer

Every three minutes someone in the United States is diagnosed with blood cancer – and around half of those cancers are lymphoma. Learn key facts on symptoms, diagnosis and prevalence of Marginal Zone Lymphoma (MZL).

Five Breast Cancer Facts You Should Know

The San Antonio Breast Cancer Symposium, December 6 - 10, brings together academic researchers and health care professionals to share the latest research and advancements in the treatment/understanding of breast cancer.

Our Commitment to the Most Common Adult Leukemia

Learn more about the symptoms and treatment of chronic lymphocytic leukemia (CLL).

AbbVie Honored with Global Citizen Award

International Medical Corps celebrates its partnership with AbbVie that brings medical, psycho-social and disaster support to vulnerable populations.

AbbVie Proud of Our National Merit Scholars

We are pleased to participate in the National Merit Scholarship Program to recognize outstanding high school students of our employees' families.

Five Important Facts About Glioblastoma You Should Know

A particularly aggressive brain cancer called glioblastoma will be a topic of discussion at the Annual Scientific Meeting for the Society for Neuro-Oncology.

Five Things to Know About Lung Cancer

November is Lung Cancer Awareness Month and as the second most common cancer in both men and women, many people have heard of it, but may not know important facts.

Hepatitis C: Six Genotypes and Six Separate Challenges

Did you know that treating hepatitis C depends on a number of factors, including the type of hepatitis C that you have?

Survey Sheds Light on Under-Recognized Digestive Condition, EPI

While digestive conditions affect approximately 60 to 70 million in the U.S., many don’t recognize it. A new survey examines misperceptions in gastrointestinal health. 

AbbVie’s Rova-T Wins ‘Most Promising Clinical Candidate’ Award

AbbVie’s Rova-T Wins ‘Most Promising Clinical Candidate’ Award award at World Antibody Drug Conjugate Summit.